X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Biocon Ltd Fact Sheet, Biocon Ltd Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Biocon Ltd Fact Sheet   (BICN)

Here is the latest financial fact sheet of Biocon Ltd. For more details, see the Biocon Ltd quarterly results and Biocon Ltd share price and chart. For a sector overview, read our pharmaceuticals sector report.

BIOCON Price History

Price Rs 610.2
Mkt Cap Rs m 366,120
Vol '000 36.2
P/E X 40.7
P/CF X 44.8
EPS (TTM) Rs 15.0
% ch % -0.8
No. of shares m 600.00
% ch week % -3.1
% ch 1-mth % -2.7
% ch 12-mth % -2.1
52 week H/L Rs 718.4/543.8
(As on Apr 22, 2019 01:45:00 PM)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

BIOCON Financials

No. of Mths
Year Ending
12
Mar-14
*
12
Mar-15
*
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
5-Yr Chart
Click to enlarge
BIOCON  EQUITY SHARE DATA
High Rs4975544961,1621,188 
Low Rs265407397483305 
Sales per share (Unadj.) Rs143.9154.5167.4194.668.7 
Earnings per share (Unadj.) Rs20.724.930.534.47.6 
Diluted earnings per shareRs6.98.310.211.57.6 
Cash flow per share (Unadj.) Rs30.935.942.948.314.0 
Dividends per share (Unadj.) Rs5.005.005.001.001.00 
Adj. dividends per shareRs1.671.671.670.331.00 
Dividend yield (eoy) %1.31.01.10.10.1 
Book value per share (Unadj.) Rs151.3163.1201.7241.986.3 
Adj. book value per shareRs50.454.467.280.686.3 
Shares outstanding (eoy) m200.00200.00200.00200.00600.00 
Bonus/Rights/Conversions  ----IS 
Price / Sales ratio x2.63.12.74.210.9 
Avg P/E ratio x18.419.314.623.998.9 
P/CF ratio (eoy) x12.313.410.417.053.4 
Price / Book Value ratio x2.52.92.23.48.6 
Dividend payout %24.220.116.42.913.2 
Avg Mkt Cap Rs m76,19096,08089,220164,440447,900 
No. of employees `0007.37.54.49.26.1 
Total wages/salary Rs m4,6635,3346,1017,4709,311 
Avg. sales/employee Rs Th3,936.14,119.77,581.94,213.96,705.8 
Avg. wages/employee Rs Th637.9711.21,381.9809.01,514.2 
Avg. net profit/employee Rs Th566.1663.21,379.6745.2736.9 
BIOCON  INCOME DATA
Net Sales Rs m28,77330,89833,47438,91141,234 
Other income Rs m5595317921,5712,062 
Total revenues Rs m29,33231,42934,26640,48243,296 
Gross profit Rs m6,8716,9587,6789,7958,291 
Depreciation Rs m2,0362,2102,4872,7723,851 
Interest Rs m1789293260615 
Profit before tax Rs m5,3775,1905,6908,3345,887 
Minority Interest Rs m-170-310217163213 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m01,0511,60600 
Tax Rs m1,0699571,4221,6161,569 
Profit after tax Rs m4,1384,9746,0916,8814,531 
Gross profit margin %23.922.522.925.220.1 
Effective tax rate %19.918.425.019.426.7 
Net profit margin %14.416.118.217.711.0 
BIOCON  BALANCE SHEET DATA
Current assets Rs m26,38824,75039,70940,47741,486 
Current liabilities Rs m13,79615,97416,65716,78321,413 
Net working cap to sales %43.828.468.960.948.7 
Current ratio x1.91.52.42.41.9 
Inventory Days Days4856596064 
Debtors Days Days7681788394 
Net fixed assets Rs m27,30834,16940,14645,07350,661 
Share capital Rs m1,0001,0001,0001,0003,000 
"Free" reserves Rs m27,04731,62239,33847,37748,808 
Net worth Rs m30,26732,62240,33848,37751,808 
Long term debt Rs m6,0627,67120,72421,08217,898 
Total assets Rs m57,50663,31984,58193,94299,897 
Interest coverage x317.359.320.433.110.6 
Debt to equity ratio x0.20.20.50.40.3 
Sales to assets ratio x0.50.50.40.40.4 
Return on assets %7.28.07.57.65.2 
Return on equity %13.715.215.114.28.7 
Return on capital %14.414.912.812.69.6 
Exports to sales %37.133.5000 
Imports to sales %22.819.7000 
Exports (fob) Rs m10,66910,339000 
Imports (cif) Rs m6,5736,102000 
Fx inflow Rs m10,80310,99311,61412,98812,058 
Fx outflow Rs m7,7157,3718,1827,8997,348 
Net fx Rs m3,0883,6223,4325,0894,710 
BIOCON  CASH FLOW
From Operations Rs m 5,607 2,107 3,706 6,400 6,621 
From Investments Rs m -9,381 -5,087 -11,417 -4,985 -6,840 
From Financial Activity Rs m 4,260 1,862 10,676 -1,775 -2,397 
Net Cashflow Rs m 486 -1,118 3,000 -473 -2,612 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 40.4%
Foreign collaborators 20.6%
Indian inst/Mut Fund 8.4%
FIIs 10.7%
ADR/GDR 0.0%
Free float 19.9%
Shareholders 109,995
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF 20th KM, Hosur Road, Electronic City, Bangalore - 560 100
E-MAIL kiran.kumar@biocon.com WEB www.biocon.com
TELEPHONE (080) 2808 2037 FAX (080) 2852 3423
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Karvy Computershare, 17-24, Vithalrao Nagar, Madhapur, Hyderabad-81
AUDITOR S. R. Batliboi & Assoc.
CHM: Kiran Mazumdar Shaw (MD) COMP SEC: Kiran Kumar YEAR OF INC: 1978 BSE CODE: 532523 FV (Rs): 5 DIV YIELD (%): 0.2

More Pharmaceuticals Company Fact Sheets:   SANOFI INDIA  PANACEA BIOTECH  INDOCO REMEDIES  TORRENT PHARMA  ORCHID PHARMA LTD  

Compare BIOCON With:   SANOFI INDIA  PANACEA BIOTECH  INDOCO REMEDIES  TORRENT PHARMA  ORCHID PHARMA LTD  

Compare BIOCON With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades Lower; Reliance Industries & Yes Bank Top Losers(12:30 pm)

Share markets in India are presently trading on a negative note. Barring IT sector, all sectoral indices are trading in red with realty stocks.

Views on news

BIOCON LTD Announces Quarterly Results (3QFY19); Net Profit Up 169.2% (Quarterly Result Update)

Jan 28, 2019 | Updated on Jan 28, 2019

For the quarter ended December 2018, BIOCON LTD has posted a net profit of Rs 2 bn (up 169.2% YoY). Sales on the other hand came in at Rs 15 bn (up 45.6% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

BIOCON LTD Announces Quarterly Results (2QFY19); Net Profit Up 501.9% (Quarterly Result Update)

Nov 9, 2018 | Updated on Nov 9, 2018

For the quarter ended September 2018, BIOCON LTD has posted a net profit of Rs 4 bn (up 501.9% YoY). Sales on the other hand came in at Rs 13 bn (up 36.4% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

Stocks that Could Be Out of Reach Post Elections(The 5 Minute Wrapup)

Apr 9, 2019

It's a matter of time before the stocks catch the fancy of the markets and big investors.

3 Indian Stocks with Amazon-Like Potential(Profit Hunter)

Apr 10, 2019

We have identified 3 stocks with huge wealth building potential which meet our 'Click of a Button' criteria.

This Company is Making a Big Comeback and You Can Now Profit from Its Example(The 5 Minute Wrapup)

Apr 10, 2019

How Dell got its mojo back.

This is Why the Stock of Jubilant FoodWorks Went Up 1,160%(The 5 Minute Wrapup)

Apr 12, 2019

This critical business strategy has enabled companies to scale their operations faster.

Pocketing Massive Gains with HDFC And HDFC Bank(Profit Hunter)

Apr 12, 2019

Here's how one could have generated gains of Rs 59,250 in 10 days by trading HDFC and HDFC Bank with a capital of Rs 4 lakh.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TRACK BIOCON

MORE ON BIOCON

BIOCON - TORRENT PHARMA COMPARISON

COMPARE BIOCON WITH

MARKET STATS